Stead added that while SLT is now the first treatment that is offered to patients, a range of topical medications in the form ...

Please provide your email address to receive an email when new articles are posted on . BALTIMORE — Although drugs remain the first-line treatment for most glaucoma patients, many glaucoma specialists ...

Medication, laser, and surgery are all methods of treating glaucoma according to Jonathan Eisengart, MD. Jonathan Eisengart, MD, an ophthalmologist at Cleveland Clinic, explained how different ...

ViaLase, Inc., a clinical-stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced that the first patient has been treated in its U.S.

Glaucoma is one of the leading causes of permanent blindness in the world, affecting more than two million Americans, and more than one hundred million people worldwide. It is a disease of the optic ...

The role of laser treatment in glaucoma management is in flux. New procedures with safety profiles seemingly better than those of older procedures have appeared, but widespread adoption of these ...

About 3 million people in the United States have glaucoma, and it’s the second leading cause of blindness worldwide, according to the Centers for Disease Control and Prevention. While there is no cure ...

SAN FRANCISCO, California — Laser trabeculoplasty procedures can fail in 30% to 40% of patients with glaucoma, and they will need additional treatment to control their eye disease, according to 2 new ...

Have you heard about an eye condition that can lead to irreversible vision loss if not treated on time? Glaucoma is a group of eye diseases that can lead to vision loss and blindness through damage to ...

Aims To assess efficacy of trans-scleral diode laser cyclophotocoagulation in the treatment of diabetic neovascular glaucoma refractory to medical therapy. Methods Case notes of 20 eyes of 20 patients ...

Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and ...